Glycorex Catalogue FREE OLIGOSACCHARIDES AND SIMPLE GLYCOSIDES

The compounds below are of interest as e.g. reference substances, substrates for enzymes, in glycosyltransferase-, glycosidase-or lipase-catalysed reactions or as inhibitors in protein, selectin, lectin, or antibody studies.

The list of compounds below will be modified and extended upon customer demand. If you are interested in other types of oligosaccharides or glycosides, please contact us.

As mentioned above, one of our specialities is large scale synthesis. Several of the compounds below have been prepared via glycosidase-catalysed synthesis. This method allows for stereospecific production of compounds of high purity under environment-friendly conditions and also allows for scaled up production, cf. K.G.I. Nilsson, Trends in Biotechnology , 6, 256-264 (1988).

Therefore, if you are interested in bulk quantities or custom synthesis , please contact us.

Cat. No.

STRUCTURE

Quantity

F-3001

Galß1-4GlcNAc
N-Acetyllactosamine
Repeating unit in type II chains, component of Lewis-x
Substrate for e.g. sialyltransferases, inhibitor of lectins

(25 mg)
(100 mg)

F-3002

Galß1-4GlcNAcß-OEt
Ethyl ß-glycoside of F-3001
Substrate for e.g. sialyltransferases, inhibitor of lectins

(1 mg)

F-3008

Galß1-4GlcNAcß-SEt
Ethyl ß-thioglycoside of F-3001
Substrate for e.g. sialyltransferases, inhibitor of lectins

(1 mg)
(5 mg)
(25 mg)

F-3011

Galß1-3GlcNAcß-OMe
Lacto-N-biose
Repeating unit in type I chains, component of Lewis-a
Substrate for e.g. sialyltransferases

(1 mg)
(5 mg)
(25 mg)

F-3009

Galß1-3GlcNAcß-SEt
Ethyl ß-thioglycoside of F-3011
Substrate for e.g. sialyltransferases

(1 mg)
(5 mg)
(25 mg)

F-3012

GlcNAcß1-3Galß-OMe
Proposed receptor for pneumococci
Andersson B. et al., J. Exp. Med. 158 , 559 (1983)

(2 mg)

F-3021

GlcNAcß1-6Maná-OMe

(1 mg)

F-3005

GlcNAcß1-4GlcNAc
N,N'-Diacetyl chitobiose
Reducing terminal of N-linked oligosaccharides
Lectin inhibitor, Lysozyme substrate
Ischikawa, F., et al, Agric. Biol. Chem. 45 , 557 (1981)

(10 mg)
(25 mg)
(100 mg)

F-3004

GlcNAcß1-4GlcNAcß1-4GlcNAc
N,N',N''-Triacetyl chitotriose
Lectin inhibitor, studies as immunopotentiator
Ischikawa, F., et al, Agric. Biol. Chem. 45 , 557 (1981)

(5 mg)
(25 mg)

F-3019

GlcNAcß1-4GlcNAcß1-4GlcNAcß1-4GlcNAc
N,N',N'',N''',-Tetraacetyl chitotetraose
Lectin inhibitor, studies as immunopotentiator
Ischikawa, F., et al, Agric. Biol. Chem. 45 , 557 (1981)

(5 mg)
(25 mg)

F-3022

Glcá1-4Glcá1-4Glc
Maltotriose

(1 mg)
(5 mg)
(25 mg)

F-3006

Glcá1-6Glcá1-4Glcá1-4Glc
Glycogen-derived urinary tetrasaccharide
Glycogen storage disease type II
Kuriyama, M., et al., J. Biochem. (Tokyo), 98 , 1041 (1985)

(1 mg)
(5 mg)
(25 mg)

F-3025

Maná1-3Man
Nordén, et al, J. Biol. Chem., 248 , 6210 (1973)

(15 mg)
(50 mg)

F-3013

Maná1-2Maná-OMe
Substrate for á1-2-mannosidase, studies of lectins
Yamamoto et al., J. Biochem. (Tokyo), 91 1971 (1982)

(5 mg)
(25 mg)

F-3014

Maná1-3Maná-OMe
Substrate for á-mannosidase

(5 mg)
(25 mg)

Nordén, et al, J. Biol. Chem., 248 , 6210 (1973)

F-3015

Maná1-6Maná-OMe

3
Maná1

Carbohydrate core structure of N-linked oligosaccharides

(5 mg)
(25 mg)

Substrate for GlcNAc-transferases

F-3003

Galá1-4Gal
Receptor for uropathogenic E. coli

(5 mg)
(25 mg)

Potential inhibitor of infections in the urinary tract

Källenius et al., Lancet, 604 (1981)

F-3016

Galá1-4Galß-OEt
Ethyl glycoside of F-3003

(5 mg)
(25mg)

F-3024

Galß1-4Galß1-4Glc
ß-analog of Globotriose (P

(1 mg)
(5 mg)

F-3017

Galá1-3Gal
á1-3 Galactobiose, linear B disaccharide

(5 mg)
(25 mg)

Xeno-Antigen on Pig Organs, cancer -associated antigen

Proposed receptor for pathogenic E. coli K88+ causing diarrhea in piglets

F-3018

Galá1-3Galá-OMe
Methyl glycoside of F-3017

(5 mg)
(25 mg)

F-3023

Galá1-3Galß1-4GlcNAcß1-3Galß1-4Glc
Xeno-Antigen on Pig Organs

(10 mg)

F-3020

Galß1-3Galß-OMe
ß-Stereoisomer of the Xeno-Antigen

(2 mg)
(10 mg)

F-3007

Galß1-3GalNAc

(2 mg)

TF-Antigen

F-3026

GalAá1-4GalA
Digalacturonic Acid

(10 mg)
(100 mg)

F-3027

GalAá1-4GalAá1-4GalA
Trigalacturonic Acid

(10 mg)
(100 mg)

F-3028

Fucá1-2Galß1-4Glc
2'-Fucosyllactose

(5 mg)

F-3029

Galß1-4(Fucá1-3)Glc
3-Fucosyllactose
Glucose analog of Lewis-x

(2 mg)

F-3030

Neu5Acá2-3Galß1-4Glc
3'-Sialyllactose
Haverkamp et al, Eur. J. Biochem., 122 , 305 (1982)

(1 mg)

F-3031

Neu5Acá2-6Galß1-4Glc
6'-Sialyllactose
Haverkamp et al, Eur. J. Biochem., 122 , 305 (1982)

(1 mg)
(2 mg)

F-3032

Galß1-3GlcNAcß1-3Galß1-4Glc
Lacto-N-Tetraose (LNT)
Dua and Busch, Anal. Biochem., 133, 1 (1983)

(2 mg)
(10 mg)

F-3033

Fucá1-2Galß1-3GlcNAcß1-3Galß1-4Glc
Lacto-N-Fucopentaose-1 (LNF-1), human milk saccharide
Contains the blood group O(H) Type I Determinant
Dua and Busch, Anal. Biochem., 133 , 1 (1983)

(1 mg)
(5 mg)
(25 mg)

F-3034

Galß1-4(Fucá1-3)GlcNAcß1

Galß1-3GlcNAcß1

-6
-G
-3

alß1-4Glc

Monofucosyllacto-N-Hexaose (MFLNH-III), human milk saccharide
Contains the Lewis-x antigen, Dua et al,J. Chromatogr. 328, 259 (1985)

(1 mg)
(5 mg)

F-3035

Fucá1-2G alß1-3G
Fucá1-4

lcNAcß1-3Galß1-4Glc

Lacto-N-Difucohexaose-1 (LND-I), human milk saccharide
Contains the Lewis-b antigen
Dua and Busch, Anal. Biochem., 133 , 1 (1983)

(1 mg)
(5 mg)

F-3036

Galß1-4(Fucá1-3)GlcNAcß1

Fucá1-2Galß1-3(Fucá1-4)GlcNAcß1

-6
-G
-3

alß1-4Glc

Trifucosyllacto-N-Hexaose, human milk saccharide
Contains both the Lewis-x and the Lewis-b antigen
Sabharwal et al, Carbohydr. Res. 178, 145 (1988)

(1 mg)
(5 mg)

F-3037

Neu5Acá2-6Galß1-4GlcNAcß1-3Galß1-4Glc
Sialyllacto-N-neotetraose-c (LST-c), human milk saccharide
Kuhn and Gauhe, Chem. Ber., 98, 395 (1965)

(1 mg)

F-3038

Neu5Acá2-6
Neu5Acá2-3Galß1-3G

lcNAcß1-3Galß1-4Glc

Disialyllacto-N-tetraose (DSLNT), human milk saccharide
Grimmonprez and Montreuil, Bull Soc. Chim. Biol., 50, 843 (1968)

(1 mg)

F-3039

Galá1-3Galß1-4GlcNAc

(10 mg)